Tag Archives: anvisa

Americas Health Authorities Meeting

Posted on February 24, 2014 by Maria I. Guaia

On the 20th and 21st of February of 2014, representatives of the five Latin-American Health Authorities of Regional Reference recognized by the Pan American Health Organization, plus those of the FDA, Health Canada, and El Salvador’s regulatory agency met in … Continue reading →

Posted in Argentina, Brazil, Canada, Colombia, Cuba, Mexico, Uncategorized, USA | Tagged , , , , , , , , , , , , , , , , , , , , , | 2 Comments

Brazil: ANVISA bans Lorcaserin (Belviq)

Posted on November 6, 2013 by Maria I. Guaia

Today ANVISA, the Brazilian health authority with competence on the control of pharmaceutical products and APIs, banned the manufacturing, import, commercialization, manipulation and use of the API Lorcaserin. Lorcaserin is the drug substance of Belviq, an innovative weight-loss product that … Continue reading →

Posted in Brazil | Tagged , , , , , , , , , , , , | 3 Comments

Brazil: Overview of API registration

Posted on October 28, 2013 by Maria I. Guaia

In Brazil, the health authority (ANVISA) will require that all Active Pharmaceutical Ingredients (APIs) manufactured in Brazil, imported for manufacturing of drug products, or included in imported finished products, are registered with the agency. This regulation has been put in … Continue reading →

Posted in Brazil | Tagged , , , , , , , | 8 Comments